Inventage Lab Inc.
Biopharmaceutical company developing advanced drug delivery systems.
389470 | KO
Overview
Corporate Details
- ISIN(s):
- KR7389470006
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 중원구 둔촌대로388번길 24, 101호, 601호, 612호, 성남시
Description
Inventage Lab Inc. is a biopharmaceutical company specializing in the development of advanced Drug Delivery Systems (DDS). The company's foundation is its proprietary microfluidics-based platform technology, Laminar-FluiDigm™, which is applied to pharmaceutical research and manufacturing. Inventage Lab operates two primary platforms: IVL-DrugFluidic® for developing and producing microsphere-based long-acting injectables, and IVL-GeneFluidic® for the formulation and manufacturing of Lipid Nanoparticles (LNPs) for nucleic acid and gene therapies. The company's pipeline is focused on treating chronic and refractory diseases, with key programs targeting androgenic alopecia (male pattern baldness) and Alzheimer's disease. Other development areas include drug re-discovery for conditions like rheumatic arthritis and multiple sclerosis, and collaborative projects for HIV treatments and mRNA-based therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2026-01-07 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | HTML • 83.1 KB | ||
| 2026-01-05 00:00 |
전환청구권행사 (제2회차)
|
Korean | HTML • 8.6 KB | ||
| 2025-12-18 00:00 |
[기재정정]주권관련사채권의취득결정
|
Korean | HTML • 43.6 KB | ||
| 2025-12-16 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 24.7 KB | ||
| 2025-10-21 00:00 |
소송등의판결ㆍ결정 (신주상장금지 등 가처분-취하)
|
Korean | HTML • 5.3 KB | ||
| 2025-10-21 00:00 |
소송등의판결ㆍ결정 (신주발행무효 확인의 소-취하)
|
Korean | HTML • 5.1 KB | ||
| 2025-10-20 00:00 |
주요사항보고서(소송등의제기)
|
Korean | HTML • 6.7 KB | ||
| 2025-10-20 00:00 |
주요사항보고서(소송등의제기)
|
Korean | HTML • 7.3 KB | ||
| 2025-09-23 00:00 |
전환청구권행사 (제2회차)
|
Korean | HTML • 8.6 KB | ||
| 2025-09-22 00:00 |
전환청구권행사 (제2회차)
|
Korean | HTML • 8.7 KB | ||
| 2025-09-10 00:00 |
투자판단관련주요경영사항(임상시험결과) (알코올 의존성 및 opioid 의존성 치료제(IVL3004) 및 다발성 경화증 …
|
Korean | HTML • 15.3 KB | ||
| 2025-08-27 00:00 |
반기보고서 (2025.06)
|
Korean | HTML • 1.6 MB | ||
| 2025-08-08 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 24.4 KB | ||
| 2025-08-08 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 25.2 KB | ||
| 2025-07-31 00:00 |
투자판단관련주요경영사항 (FGF-21기반 mRNA-LNP 대사성 질환치료제 독점적 권리 도입 계약 체결)
|
Korean | HTML • 10.9 KB |
Automate Your Workflow. Get a real-time feed of all Inventage Lab Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Inventage Lab Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Inventage Lab Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
